Home/Hedge Fund Intelligence/Viking Therapeutics, Inc.
Nasdaq: VKTXStockForm 13F30 Jun 2026

Hedge funds that hold Viking Therapeutics, Inc. Nasdaq: VKTX

CUSIP 92686J106 · who reports it, how much, and how much it matters to them

39 of the 720 hedge fund managers we track reported shares of Viking Therapeutics, Inc. (Nasdaq: VKTX) on Form 13F for 30 June 2026. Between them they reported USD 416m. The largest position belongs to Two Sigma Investments, at USD 154m. The manager with the most riding on it is Blackbarn Capital Partners, where it is 2.0% of the reported book.

Managers reporting it39of 720 we track
Value they reportUSD 416mshares only, 30 Jun 2026
Funds they run799with a file on PPLI.com
Largest positionUSD 154mTwo Sigma Investments
Typical weight0.0%median share of a manager's book
Heaviest weight2.0%Blackbarn Capital Partners

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

39 managers, USD 416m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Viking Therapeutics, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Two Sigma Investments35 funds on PPLI.comUSD 154m0.1%
2D. E. Shaw & Co.15 funds on PPLI.comUSD 63m0.0%
3Citadel Advisors32 funds on PPLI.comUSD 37m0.0%
4Eversept Partners3 funds on PPLI.comUSD 24m1.2%
5Blackbarn Capital Partners1 fund on PPLI.comUSD 23m2.0%
6Millennium Management6 funds on PPLI.comUSD 19m0.0%
7POINT72 Asset Management17 funds on PPLI.comUSD 18m0.0%
8Exoduspoint Capital Management7 funds on PPLI.comUSD 14m0.1%
9PFM Health Sciences3 funds on PPLI.comUSD 10m0.9%
10Tudor Investment Corporation10 funds on PPLI.comUSD 7.7m0.0%
11Artia Global Partners1 fund on PPLI.comUSD 7.1m1.3%
12Balyasny Asset Management25 funds on PPLI.comUSD 4.5m0.0%
13Persistent Asset Partners10 funds on PPLI.comUSD 4.4m1.3%
14Bridgewater Associates45 funds on PPLI.comUSD 3.4m0.0%
15Capital Fund Management S.A.12 funds on PPLI.comUSD 2.9m0.0%
16Dafna Capital Management6 funds on PPLI.comUSD 2.3m0.4%
17Schonfeld Strategic Advisors30 funds on PPLI.comUSD 2.1m0.0%
18Campbell & Company Investment Adviser8 funds on PPLI.comUSD 2m0.1%
19Exome Asset Management2 funds on PPLI.comUSD 1.9m1.2%
20Engineers Gate Manager1 fund on PPLI.comUSD 1.8m0.0%
21Marshall Wace LLP84 funds on PPLI.comUSD 1.7m0.0%
22Squarepoint Ops7 funds on PPLI.comUSD 1.6m0.0%
23Lighthouse Investment Partners190 funds on PPLI.comUSD 1.4m0.0%
24Kintayl Capital2 funds on PPLI.comUSD 1.1m0.5%
25Brevan Howard Capital Management39 funds on PPLI.comUSD 1.1m0.0%
26Rock Springs Capital Management2 funds on PPLI.comUSD 995,0000.0%
27Graham Capital Management18 funds on PPLI.comUSD 863,0000.0%
28Oxford Asset Management LLP2 funds on PPLI.comUSD 633,0000.3%
29Fulcrum Asset Management LLP7 funds on PPLI.comUSD 606,0000.1%
30J. Goldman & Co.1 fund on PPLI.comUSD 589,0000.0%
31Water Island Capital1 fund on PPLI.comUSD 585,0000.1%
32Scientech Research2 funds on PPLI.comUSD 564,0000.5%
33Brandywine Managers47 funds on PPLI.comUSD 480,0000.2%
34Magnetar Financial93 funds on PPLI.comUSD 443,0000.0%
35Walleye Capital8 funds on PPLI.comUSD 441,0000.0%
36Arrowmark Colorado Holdings24 funds on PPLI.comUSD 385,0000.0%
37Lecap Asset Management1 fund on PPLI.comUSD 318,0000.1%
38Bayforest Capital1 fund on PPLI.comUSD 83,5200.1%
39The Quarry1 fund on PPLI.comUSD 1,0920.0%
Next: where it matters most
Where it matters most

For Blackbarn Capital Partners it is 2.0% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Blackbarn Capital PartnersUSD 23m2.0%
2Persistent Asset PartnersUSD 4.4m1.3%
3Artia Global PartnersUSD 7.1m1.3%
4Eversept PartnersUSD 24m1.2%
5Exome Asset ManagementUSD 1.9m1.2%
6PFM Health SciencesUSD 10m0.9%
7Scientech ResearchUSD 564,0000.5%
8Kintayl CapitalUSD 1.1m0.5%
9Dafna Capital ManagementUSD 2.3m0.4%
10Oxford Asset Management LLPUSD 633,0000.3%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Viking Therapeutics, Inc.

What is the ticker symbol of Viking Therapeutics, Inc.?

Viking Therapeutics, Inc. trades under the symbol VKTX on the Nasdaq. Its CUSIP, the code used on Form 13F, is 92686J106.

Which hedge funds own Viking Therapeutics, Inc. (Nasdaq: VKTX)?

39 of the 720 hedge fund managers PPLI.com tracks reported Viking Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Two Sigma Investments (USD 154m), D. E. Shaw & Co. (USD 63m), Citadel Advisors (USD 37m), Eversept Partners (USD 24m) and Blackbarn Capital Partners (USD 23m).

How many hedge funds hold Viking Therapeutics, Inc.?

39 managers in our coverage reported it, and between them they run 799 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Viking Therapeutics, Inc.?

Blackbarn Capital Partners, where the position was 2.0% of the reported 13F book at 30 June 2026.

Does this show who is short Viking Therapeutics, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Viking Therapeutics, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.